Biotech and Money Ltd.

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 6 days ago

New blog articles detected.

  • Interview with Daniel Oliver, CEO of Capital Cell

    Daniel Oliver, CEO of Capital Cell, recently took the time to grant us an interview. Capital Cell is the first European platform of equity crowdfunding in biotech projects. In this exclusive interview, Daniel tells us more about the approach they are taking as a company that sets them apart from other companies in the space, the misconceptions about crowdfunding and why the Life Scienc...

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 6 days ago

New blog articles detected.

  • Investorview – Zishan Haroon, Chairman & General Partner at ‎Julz Co

    In a new regular feature for Drugs & Dealers, we’ll be interviewing some of the most interesting and active investors in our growing community. This week, we spoke to Zishan Haroon, Chairman & General Partner at ‎Julz Co, who focus on therapeutics, diagnostics and digital health investments across Europe and the US, but with an Asian connection…

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 6 days ago

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 1 week ago

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 1 week ago

New blog articles detected.

  • [VIDEO INTERVIEW] Developing Cellular Immunotherapies using Regulatory T Cells

    Straight from the Investment for Advanced Therapies hosted by CMS Cameron-McKenna on Wednesday 3rd May, we sat down with Stéphane Boissel, CEO of TxCEll, to find out more about the unique development of their cellular immunotherapies using regulatory T Cells to treat severe inflammatory and autoimmune disease. In this video interview, Stéphane also explains why their CAR Treg platform ...

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 3 weeks ago

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 1 month ago

New blog articles detected.

  • The 'Davos' of Life Sciences

    Conversations within the Biotech & Money C-level community have told us there’s a genuine need for a European equivalent to the ‘JP Morgan Week’. Alongside our pre-existing partnership with the annual Jefferies 2017 Global Healthcare Conference in London in November, we’ve set about creating just that.

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 1 month ago

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 1 month ago

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 1 month ago

New blog articles detected.

  • IPO and M&A Bootcamps

    Dealing with the challenges of growing your business it can turn really perplexing and difficult to ensure you remain on track. It’s important to ensure you are prepared, so we invite you to the Biotech and Money’s 2nd IPO Bootcamp and 1st M&A Bootcamp on the 14 of September, coinciding with our annual Gala Dinner and Awards ceremony. In line with our mission to support funding, financ...

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 1 month ago

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 1 month ago

New blog articles detected.

  • Interview with Dr Sara Nunez-Garcia, Principal, Sofinnova Partners

    Phacilitate's Investment for Advanced Therapies in partnership with Biotech and Money will take place May 3 at the CMS offices in London, and brings together investors, pharma and biotech into the same room to discuss the latest industry developments, areas that need investment to develop to their full potential and how this can all be turned into a profitable venture for all involved.

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 1 month ago

New blog articles detected.

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 1 month ago

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 1 month ago

New blog articles detected.

  • [Video interview] What are the challenges for early stage investment in advanced therapies?

    As Phacilitate prepares to launch their Investment in Advanced Therapies Summit (London, 3rd May) in partnership with Biotech and Money, they caught up with Bill Podd (Landmark Capital) on what are the challenges in early stage investment for the biotech industry. At their bioleaders event in January, they had the chance to catch up with William Podd, Founder, President and CEO of Land...

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

New blog articles detected.

  • Bionure breaks the records raising more than 1M€

    Highlights Capital Cell’s crowdfunding campaign - Bionure - overfunds with more than €1M and becomes Spain’s largest ever life science equity crowdfunding campaign. With this campaign Bionure will now be able to take the next imperative step and begin promising phase-I clinical trials for their novel first-in-class drug for the treatment of mult...

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

New blog articles detected.

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

New blog articles detected.

  • Investment for advanced therapies

    Investment for Advanced Therapies will be the C-Level meeting place for heavyweight investors, analysts, biotechs, venture partners and industry experts who are driving the industry forward. Don’t miss your chance to shape the future and put your company on the map!

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

New blog articles detected.

  • Open Window in the West? Deciding whether to pursue a US IPO

    By Kristian Wiggert Partner Covington & Burling LLP, London The recent strong performance in the equity capital markets has led some commentators to predict that 2017 will be a good year for IPOs. US markets have performed particularly well and there have already been some successful IPOs on US exchanges. This has led to renewed interest in US IPOs among life sciences companies...

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

New blog articles detected.

  • Biotechs and the City Spring on 30th March, London

    Biotechs and the City Spring is the latest quarterly networking event for senior life science executives organised by Biotech and Money. The 3hr evening function will serve as an informal forum for up to 70 senior executives to come together, network and enjoy a relaxed evening with their peers and protégés, together with timely and pertinent presentations.

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

New blog articles detected.

  • Issue 11, Drugs & Dealers Magazine Released

    Biotech and Money are pleased to announce the release of the latest Drugs & Dealers Magazine. This is issue 11 of the bi-monthly publication aimed at providing insight, foresight and hindsight to life science executives involved in funding, investment, partnering and deal making.

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

New blog articles detected.

  • 10 Things we learned from Medicines Discovery Catapult CEO Chris Molloy

    With a strong focus on the collaboration needed to solve problems common to all members of the medicines discovery community, the Medicines Discovery Catapult is a badly needed newcomer to the scene. Think of them as an enabler: a group dedicated to facilitating communication and cooperation between different branches and sectors, with the aim of initiating collaborations that might no...

  • Welcome to the Investor Portal

    Our Investor Portal is a unique, powerful and searchable resource and library showcasing 100+ Life Science companies that have recently presented an Inv€$table Showcase at one of Biotech and Money's investment conferences. Good news is qualified investors can now watch their video pitch, view their slide deck, study their profile and connect securely with the CEOs of the companies attr...

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 3 months ago

New blog articles detected.

  • What you missed at Biotech and Money London 2017

    On the 7th and 8th February 2017, our 3rd annual conference continued our relentless focus on quality peer-2-peer discussion, high level networking and partnering, unique formats and a vetted, high-calibre audience, we bring together the people that matter to the future of healthcare and life science funding, finance, investment and deal making.

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 3 months ago

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 3 months ago

New blog articles detected.

  • How Medtech Companies attract investment?

    What are the key factors for medtechs to attract investment?

  • 40+ Must Know Life Science Investors

    Who are some of the leading international investors most active this side of the Atlantic?  This ebook is a summary of over 40 of the life science industry’s most notable and active venture capital, corporate venture, strategic investors and PE / crossovers. The geography of this list is primarily UK and EU, but with several key US firms also listed. They represent a combined assets u...

  • What was the Biotech and Money Inv€$tival Showcase

    We were delighted to partner with the global investment bank Jefferies to launch the Biotech and Money Inv€$tival Showcase, co-located with the Jefferies 2016 London Healthcare Conference.

  • What is Medtech?

    Medtech is a very broad sector – it covers any technology that can be used in a care setting, which covers disposables, capital equipment and surgical procedure innovations, through to implant technology, biomaterials and connected health IT. Medtech accounts for all devices with which a patient can be diagnosed or treated: in diagnostics, a medical device is typically used in or on th...

  • How to make your IP investable

    At the core of any biotech company is an innovative piece of science which is believed will lead to new and beneficial healthcare products. The company’s Directors and advisors use their scientific insight and business acumen to push these new healthcare products along the road towards market.

  • Announcing the Launch of Biotech and Money's Healthcare Investor Insight Survey 2017

    Biotech and Money is proud to announce the launch of our inaugural Healthcare Investor Insight Survey and Report. The results and highlights of the report will be shared at the Biotech and Money London conference on 7-8 February, where you will also be able to acquire a copy.

  • How to make your IP investable

    This is the second in a series of four articles which aim to provide tips for creating and maintaining a patent portfolio that genuinely provides a biotech company with the hoped for IP position and makes it an attractive choice for investors. The first article focused on building a robust and investable patent portfolio.

  • 35+ Innovative Life Science Companies you'll want to meet in 2017

    Who are the innovative biotech and medtech companies presenting at Biotech and Money / Medtech and Money London 2017?

  • Of Mice and Men: Kymab scurries up the biologics ladder

    Using the pioneering Kymouse human antibody expression platform, Kymab are paving the way to a new era of antibody-based medicine. Already boasting two antibodies on their way to the clinic, Kymab’s investors are drawn to the platform’s breadth and potential, as 2020 promises to see a further four antibodies undergoing clinical trials. With distinguished investors such as the Wellcome ...

  • The role of SFOs in the Healthcare Sector

    Our ongoing mission at Biotech and Money is to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. One of the key ways we do that is by talking to and, more importantly, listening to our community. A topic that seemed to we’ve found to be of almost universal interest to companies of all sizes in...

Out-Market Your Competitors?

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account Log in

Out-Market Your Competitors

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account

Already a user?  Log in